MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells.
about
Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast CancerThe Emerging Role of miRNAs in HTLV-1 Infection and ATLL PathogenesisCombinatorial effects of miR-20a and miR-29b on neuronal apoptosis induced by spinal cord injury.miR-378a-3p modulates tamoxifen sensitivity in breast cancer MCF-7 cells through targeting GOLT1A.Disulfiram chelated with copper promotes apoptosis in human breast cancer cells by impairing the mitochondria functions.TIP60-miR-22 axis as a prognostic marker of breast cancer progression.Cdk3-promoted epithelial-mesenchymal transition through activating AP-1 is involved in colorectal cancer metastasisA novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancerCDK3, target of miR-4469, suppresses breast cancer metastasis via inhibiting Wnt/β-catenin pathway.MTA1 is a novel regulator of autophagy that induces tamoxifen resistance in breast cancer cells.A support vector machine and a random forest classifier indicates a 15-miRNA set related to osteosarcoma recurrence.Novel SYK gene variations and changes in binding sites of miRs in breast cancer patients.Functional miRNAs in breast cancer drug resistance.MiR-873 inhibition enhances gefitinib resistance in non-small cell lung cancer cells by targeting glioma-associated oncogene homolog 1
P2860
Q26773907-15B8A6F4-6BF6-4157-8FE4-D33ABCDE2A38Q26800055-4CE476AF-8D46-4A22-B05A-AC17B298DE59Q35741028-472371DB-FB84-4F3A-9722-F0D702CE52D1Q35932634-62E8AA17-F086-4444-91F6-EE44DDC7A10AQ36063610-054BE98D-7DE1-4B61-9ACF-E687632F8C23Q36562356-AF2E4D84-F8F7-404E-8D5B-4408AED584B4Q36916409-BBBC3DE3-EFC3-4690-9BC4-1BDF248414C5Q37046721-7C3B0C7E-2DE4-4437-ABC3-784C6E2B7E29Q43951442-153CB852-A879-44A1-A33A-EE901276CBB9Q47410836-58888914-8915-47B4-A2AD-AC2B7E7A02BAQ49263961-CDE556C5-C631-46C5-B9B3-8D011BEBD31BQ54214140-A72722AC-A5E7-41D6-ACCC-7D10DD21C4BBQ55000578-AE34BCDD-8FAC-4F3A-98BD-2618EA801750Q58732696-A56FD73E-5345-4A1A-97B2-497E5A6F72CE
P2860
MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
MiR-873 regulates ERα transcri ...... g CDK3 in breast cancer cells.
@en
type
label
MiR-873 regulates ERα transcri ...... g CDK3 in breast cancer cells.
@en
prefLabel
MiR-873 regulates ERα transcri ...... g CDK3 in breast cancer cells.
@en
P2093
P2860
P356
P1433
P1476
MiR-873 regulates ERα transcri ...... g CDK3 in breast cancer cells.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2014.430
P407
P577
2014-12-22T00:00:00Z
P5875
P6179
1033351931